SCHEMBL324258

SCHEMBL324258

CC(C)(N)C(C)(C)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1569376 0.78
SCHEMBL4302756 0.78
SCHEMBL28523102 0.78
SCHEMBL10908610 0.76
Hydrochloric Acid SCHEMBL5891757 0.74
Hydrochloric Acid SCHEMBL28881157 0.74
SCHEMBL2013017 0.73
SCHEMBL6017395 0.73
SCHEMBL10425917 0.72 FDPS (0.31)
SCHEMBL15333 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121518068-B Bonding emulsion containing core-shell microspheres and preparation method thereof 拓迪化学(上海)股份有限公司 2026-05-19 CN disclosed
EP-3389795-B1 OCCLUSIVE PERSONAL CARE COMPOSITION COLGATE PALMOLIVE CO (US) 2021-12-01 EP disclosed
US-10590413-B2 Chiral control WAVE LIFE SCIENCES LTD. (SG) 2020-03-17 US disclosed
EP-3389795-A1 OCCLUSIVE PERSONAL CARE COMPOSITION Colgate-Palmolive Company (US) 2018-10-24 EP disclosed
US-9861562-B2 Occlusive personal care composition COLGATE-PALMOLIVE COMPANY (US) 2018-01-09 US disclosed
US-9750719-B2 Tetrazole compounds as calcium channel blockers Convergence Pharmaceuticals Limited (GB) 2017-09-05 US disclosed
US-20170172868-A1 OCCLUSIVE PERSONAL CARE COMPOSITION COLGATE-PALMOLIVE COMPANY 2017-06-22 US disclosed
WO-2017105438-A1 OCCLUSIVE PERSONAL CARE COMPOSITION COLGATE-PALMOLIVE COMPANY (US) 2017-06-22 WO disclosed
US-20160015687-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2016-01-21 US disclosed
US-9115132-B2 Tetrazole compounds as calcium channel blockers Convergence Pharmaceuticals Limited (GB) 2015-08-25 US disclosed
EP-2590953-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2013-05-15 EP disclosed
US-20130072499-A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS Convergence Pharmaceuticals Limited 2013-03-21 US disclosed
EP-2533782-A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS Convergence Pharmaceuticals Limited (GB) 2012-12-19 EP disclosed
WO-2012098400-A1 PIPERAZINE DERIVATIVES AS CAV2.2 CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2012-07-26 WO disclosed
WO-2012004604-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2012-01-12 WO disclosed
WO-2011086377-A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS Convergence Pharmaceuticals Limited (GB) 2011-07-21 WO disclosed
EP-1907343-A2 PRODUCTION PROCESSES AND SYSTEMS, COMPOSITIONS, SURFACTANTS, MONOMER UNITS, METAL COMPLEXES, PHOSPHATE ESTERS, GLYCOLS, AQUEOUS FILM FORMING FOAMS, AND FOAM STABILIZERS GREAT LAKES CHEMICAL CORPORATION (US) 2008-04-09 EP disclosed
WO-2007016359-A2 PRODUCTION PROCESSES AND SYSTEMS, COMPOSITIONS, SURFACTANTS, MONOMER UNITS, METAL COMPLEXES, PHOSPHATE ESTERS, GLYCOLS, AQUEOUS FILM FORMING FOAMS, AND FOAM STABILIZERS GREAT LAKES CHEMICAL CORPORATION (US) 2007-02-08 WO disclosed
US-4500662-A STABILIZERS OF POLYMERIC MATERIALS AGAINST ULTRAVIOLET DEGRADATION THE B. F. GOODRICH COMPANY (US) 1985-02-19 US disclosed
US-4473694-A Process for the preparation of polysubstituted α-aminoacetamides THE B. F. GOODRICH COMPANY (US) 1984-09-25 US disclosed